OTIS W. BRAWLEY - Director at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
LYEL on Nasdaq
All Insider Reports
All Insider Reports

OTIS W. BRAWLEY - trading volume in the past year for Lyell Immunopharma, Inc.

Holdings reported by OTIS W. BRAWLEY for Lyell Immunopharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 35,640 $16,750 $0.4700 15 May 2025 Direct
Option (right to buy) 130,000 15 May 2025 Direct Common Stock
Option (right to buy) 130,000 14 Jun 2024 Direct Common Stock

Transactions reported by OTIS W. BRAWLEY for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.